KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Gross Margin (2017 - 2026)

Twist Bioscience has reported Gross Margin over the past 10 years, most recently at 51.59% for Q1 2026.

  • Quarterly Gross Margin rose 199.0% to 51.59% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 52.07% through Mar 2026, up 537.0% year-over-year, with the annual reading at 50.72% for FY2025, 811.0% up from the prior year.
  • Gross Margin was 51.59% for Q1 2026 at Twist Bioscience, down from 52.05% in the prior quarter.
  • Over five years, Gross Margin peaked at 53.4% in Q2 2025 and troughed at 30.76% in Q1 2023.
  • The 5-year median for Gross Margin is 44.88% (2022), against an average of 44.21%.
  • Year-over-year, Gross Margin tumbled -1045bps in 2023 and then surged 1025bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 45.72% in 2022, then fell by -11bps to 40.51% in 2023, then grew by 19bps to 48.29% in 2024, then grew by 8bps to 52.05% in 2025, then fell by -1bps to 51.59% in 2026.
  • Per Business Quant, the three most recent readings for TWST's Gross Margin are 51.59% (Q1 2026), 52.05% (Q4 2025), and 51.35% (Q3 2025).